William V. Tamborlane, M.D., professor of pediatrics and a world-renowned figure in the understanding and treatment of childhood diabetes, has been awarded the T2-Translation Award by the Society for Clinical and Translational Science (SCTS).
The award recognizes the translation of research from early clinical use to applicability for widespread clinical practice. The award honors Tamborlane’s pioneering clinical research, which has led to new delivery methods for physiological replacement of insulin, preventing many of the major long-term complications of childhood diabetes.
Tamborlane is chief of the Section of Pediatric Endocrinology and deputy director of the Yale Center for Clinical Investigation. His major achievements have included pioneering work in the development of insulin pump therapy, continuous glucose monitoring, sensor-augmented pumps, and a prototype design for an artificial pancreas. Tamborlane has also demonstrated the role of insulin resistance in pediatric metabolic disorders, including obesity and type 2 diabetes.
The SCTS presented Tamborlane with the award on April 28, at the national joint meeting of the Association for Clinical Research Training, the American Federation for Medical Research, and the SCTS, in association with the Association for Patient-Oriented Research.
Tamborlane’s multitude of honors and distinctions include the Outstanding Physician Clinician in Diabetes Award from the American Diabetes Association in 2010.